Abstract

PURPOSE: To assess quality of life and climacteric symptoms in women with and without liver transplants. METHODS: This was a cross-sectional study of 52 women undergoing follow-up at a university hospital in southeastern Brazil from February 4th, 2009 to January 5th, 2011. Twenty-four of these women were 35 years old or older and had undergone liver transplantation at least one year before study entry. The remaining 28 women had no liver disease and were matched by age and menstrual patterns to the patients with transplants. The abbreviated version of the World Health Organization (WHOQOL-BREF) questionnaire was used to assess quality of life. Menopausal symptoms were assessed using the Menopause Rating Scale (MRS). Statistical analysis was carried out by Student's t-test, Mann-Whitney test and analysis of variance. Correlations between MRS and the WHOQOL-BREF were established by correlation coefficients. RESULTS: The mean age of the women included in the study was 52.2 (±10.4) years and the mean time since transplantation was 6.1 (±3.3) years. Women with liver transplants had better quality of life scores in the environment domain (p=0.01). No difference was noted between the two groups in any domain of the MRS. For women in the comparison group, there was a strongly negative correlation between somatic symptoms in the MRS and the physical domain of the WHOQOL-BREF (p<0.01; r=-0.8). In contrast, there was only a moderate association for women with liver transplants (p<0.01; r=-0.5). CONCLUSIONS: Women with liver transplants had better quality of life scores in the domain related to environment and did not exhibit more intense climacteric symptoms than did those with no liver disease. Climacteric symptoms negatively influenced quality of life in liver transplant recipients, although less intensely than in women without a history of liver disease.

Highlights

  • Liver transplantation aims to prolong the survival of patients with end-stage liver disease

  • The aim of this study was to obtain an accurate understanding of how liver transplantation influences quality of life and menopausal symptoms in women

  • We correlated menopausal symptoms with quality of life scores to measure the effect of these symptoms on quality of life in liver transplant recipients

Read more

Summary

Introduction

Liver transplantation aims to prolong the survival of patients with end-stage liver disease. Previous studies have shown that patients undergoing liver transplantation have alterations in quality of life, with increased fatigue, physical problems and a higher prevalence of depression and anxiety after transplantation than before it[3,4,5,6]. Despite resulting in some negative changes, liver transplantation leads to an overall improved quality of life for patients and their caregivers and companions[7,8]. This improvement often becomes apparent three to five years after transplantation, by which time patients typically achieve a new level of psychosocial stability[9]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call